- Home
- BNR vs ENLV Comparison
BNR vs ENLV Comparison
Compare BNR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- ENLV
- Stock Information
- Founded
- BNR 2014
- ENLV 2005
- Country
- BNR China
- ENLV Israel
- Employees
- BNR 674
- ENLV N/A
- Industry
- BNR Medical Specialities
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- ENLV Health Care
- Exchange
- BNR Nasdaq
- ENLV Nasdaq
- Market Cap
- BNR 38.3M
- ENLV 23.7M
- IPO Year
- BNR 2020
- ENLV 1995
- Fundamental
- Price
- BNR $4.22
- ENLV $1.23
- Analyst Decision
- BNR
- ENLV Strong Buy
- Analyst Count
- BNR 0
- ENLV 2
- Target Price
- BNR N/A
- ENLV $10.00
- AVG Volume (30 Days)
- BNR 29.7K
- ENLV 133.5K
- Earning Date
- BNR 08-21-2025
- ENLV 08-29-2025
- Dividend Yield
- BNR N/A
- ENLV N/A
- EPS Growth
- BNR N/A
- ENLV N/A
- EPS
- BNR N/A
- ENLV N/A
- Revenue
- BNR $72,112,038.00
- ENLV N/A
- Revenue This Year
- BNR $136.32
- ENLV N/A
- Revenue Next Year
- BNR N/A
- ENLV N/A
- P/E Ratio
- BNR N/A
- ENLV N/A
- Revenue Growth
- BNR 0.53
- ENLV N/A
- 52 Week Low
- BNR $2.18
- ENLV $0.81
- 52 Week High
- BNR $7.90
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- ENLV 58.80
- Support Level
- BNR $3.06
- ENLV $1.14
- Resistance Level
- BNR $3.50
- ENLV $1.38
- Average True Range (ATR)
- BNR 0.21
- ENLV 0.10
- MACD
- BNR 0.05
- ENLV 0.01
- Stochastic Oscillator
- BNR 95.65
- ENLV 44.44
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.